Tooth Forth is a prospective company specializing in oral care with primary focus on cavity prevention for both adults and children. The company will be led by a team of professional experts with over 50 years of combined experience in patient care and research. The value Tooth Forth is offering is significantly differentiated from its competitors based on its biotechnology that produces the substance capable of killing two bacteria that cause dental caries: Streptococcus mutans and Streptococcus subrinus. The formulation specifically targets bacteria that lead to cavities..
Tooth Forth’s biotechnology is brand new in the industry. Tooth Forth offers a unique, valuable, scalable, economic, and desirable dental hygienic product. The technology is highly competitive in a market segment currently dominated by companies who fail to address the main culprits of cavities but also fail to adequately address the growing demand for natural alternatives to chemical products.
Tooth Forth has the PCT patent protecting their invention in 153 countries, including North American countries.